 | • レポートコード：GIR201112516 • 出版社/出版日：GlobalInfoResearch / 2020年10月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、152ページ • 納品方法：Eメール • 産業分類：医薬品・医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本書では、インフルエンザウイルスB感染症治療薬の世界市場を調査対象にし、インフルエンザウイルスB感染症治療薬の市場概要、メーカー情報、メーカー別販売量・売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（APP-309、CF-403、GC-3106A、KIN-1400、その他）、用途別分析（クリニック、病院、その他）、市場予測（2021年～2025年）、販売チャンネル・代理店分析情報などを整理しました。 ・市場概要 ・メーカー情報：AbbVie Inc、ContraFect Corp、Amarillo Biosciences Inc、Adimmune Corp、Cadila Healthcare Ltd、Altravax Inc、Fujifilm Holdings Corporation、BioCryst Pharmaceuticals Inc、Aphios Corp、Daiichi Sankyo Company Ltd、Medicago Inc、Novavax Inc、GlaxoSmithKline Plc、Romark Laboratories LC、MedImmune LLC、Kineta Inc、Green Cross Corp、Park Active Molecules、Mucosis BV、Inovio Pharmaceuticals Inc、Vectura Group Plc、Sanofi、Vaxart Inc、TSRL Inc、SK Chemicals Co Ltd、Sanofi Pasteur SA、Shionogi & Co Ltd ・メーカー別販売量、売上、市場シェア ・インフルエンザウイルスB感染症治療薬の地域別市場分析 ・インフルエンザウイルスB感染症治療薬の北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・インフルエンザウイルスB感染症治療薬のヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・インフルエンザウイルスB感染症治療薬のアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・インフルエンザウイルスB感染症治療薬の南米市場規模2015-2020：ブラジル、アルゼンチンなど ・インフルエンザウイルスB感染症治療薬の中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・インフルエンザウイルスB感染症治療薬の種類別市場規模2015-2020：APP-309、CF-403、GC-3106A、KIN-1400、その他 ・インフルエンザウイルスB感染症治療薬の用途別市場規模2015-2020：クリニック、病院、その他 ・インフルエンザウイルスB感染症治療薬の世界市場予測2021-2025：地域別、種類別、用途別 ・販売チャンネル・代理店分析 ・調査の結果・結論 |
Market Overview
The global Influenzavirus B Infection Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Influenzavirus B Infection Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Influenzavirus B Infection Drug market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Influenzavirus B Infection Drug market has been segmented into
APP-309
CF-403
GC-3106A
KIN-1400
Others
By Application, Influenzavirus B Infection Drug has been segmented into:
Clinic
Hospital
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Influenzavirus B Infection Drug market presented in the report. This section sheds light on the sales growth of different regional and country-level Influenzavirus B Infection Drug markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Influenzavirus B Infection Drug market.
The report offers in-depth assessment of the growth and other aspects of the Influenzavirus B Infection Drug market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Influenzavirus B Infection Drug Market Share Analysis
Influenzavirus B Infection Drug competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Influenzavirus B Infection Drug sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Influenzavirus B Infection Drug sales, revenue and market share for each player covered in this report.
The major players covered in Influenzavirus B Infection Drug are:
AbbVie Inc
ContraFect Corp
Amarillo Biosciences Inc
Adimmune Corp
Cadila Healthcare Ltd
Altravax Inc
Fujifilm Holdings Corporation
BioCryst Pharmaceuticals Inc
Aphios Corp
Daiichi Sankyo Company Ltd
Medicago Inc
Novavax Inc
GlaxoSmithKline Plc
Romark Laboratories LC
MedImmune LLC
Kineta Inc
Green Cross Corp
Park Active Molecules
Mucosis BV
Inovio Pharmaceuticals Inc
Vectura Group Plc
Sanofi
Vaxart Inc
TSRL Inc
SK Chemicals Co Ltd
Sanofi Pasteur SA
Shionogi & Co Ltd
Among other players domestic and global, Influenzavirus B Infection Drug market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Influenzavirus B Infection Drug product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Influenzavirus B Infection Drug, with price, sales, revenue and global market share of Influenzavirus B Infection Drug in 2018 and 2019.
Chapter 3, the Influenzavirus B Infection Drug competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Influenzavirus B Infection Drug breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Influenzavirus B Infection Drug market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Influenzavirus B Infection Drug sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Influenzavirus B Infection Drug Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Influenzavirus B Infection Drug Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 APP-309
1.2.3 CF-403
1.2.4 GC-3106A
1.2.5 KIN-1400
1.2.6 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Influenzavirus B Infection Drug Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Clinic
1.3.3 Hospital
1.3.4 Others
1.4 Overview of Global Influenzavirus B Infection Drug Market
1.4.1 Global Influenzavirus B Infection Drug Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 AbbVie Inc
2.1.1 AbbVie Inc Details
2.1.2 AbbVie Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 AbbVie Inc SWOT Analysis
2.1.4 AbbVie Inc Product and Services
2.1.5 AbbVie Inc Influenzavirus B Infection Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 ContraFect Corp
2.2.1 ContraFect Corp Details
2.2.2 ContraFect Corp Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 ContraFect Corp SWOT Analysis
2.2.4 ContraFect Corp Product and Services
2.2.5 ContraFect Corp Influenzavirus B Infection Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Amarillo Biosciences Inc
2.3.1 Amarillo Biosciences Inc Details
2.3.2 Amarillo Biosciences Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Amarillo Biosciences Inc SWOT Analysis
2.3.4 Amarillo Biosciences Inc Product and Services
2.3.5 Amarillo Biosciences Inc Influenzavirus B Infection Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Adimmune Corp
2.4.1 Adimmune Corp Details
2.4.2 Adimmune Corp Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Adimmune Corp SWOT Analysis
2.4.4 Adimmune Corp Product and Services
2.4.5 Adimmune Corp Influenzavirus B Infection Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Cadila Healthcare Ltd
2.5.1 Cadila Healthcare Ltd Details
2.5.2 Cadila Healthcare Ltd Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Cadila Healthcare Ltd SWOT Analysis
2.5.4 Cadila Healthcare Ltd Product and Services
2.5.5 Cadila Healthcare Ltd Influenzavirus B Infection Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Altravax Inc
2.6.1 Altravax Inc Details
2.6.2 Altravax Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Altravax Inc SWOT Analysis
2.6.4 Altravax Inc Product and Services
2.6.5 Altravax Inc Influenzavirus B Infection Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Fujifilm Holdings Corporation
2.7.1 Fujifilm Holdings Corporation Details
2.7.2 Fujifilm Holdings Corporation Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Fujifilm Holdings Corporation SWOT Analysis
2.7.4 Fujifilm Holdings Corporation Product and Services
2.7.5 Fujifilm Holdings Corporation Influenzavirus B Infection Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 BioCryst Pharmaceuticals Inc
2.8.1 BioCryst Pharmaceuticals Inc Details
2.8.2 BioCryst Pharmaceuticals Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 BioCryst Pharmaceuticals Inc SWOT Analysis
2.8.4 BioCryst Pharmaceuticals Inc Product and Services
2.8.5 BioCryst Pharmaceuticals Inc Influenzavirus B Infection Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Aphios Corp
2.9.1 Aphios Corp Details
2.9.2 Aphios Corp Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Aphios Corp SWOT Analysis
2.9.4 Aphios Corp Product and Services
2.9.5 Aphios Corp Influenzavirus B Infection Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Daiichi Sankyo Company Ltd
2.10.1 Daiichi Sankyo Company Ltd Details
2.10.2 Daiichi Sankyo Company Ltd Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Daiichi Sankyo Company Ltd SWOT Analysis
2.10.4 Daiichi Sankyo Company Ltd Product and Services
2.10.5 Daiichi Sankyo Company Ltd Influenzavirus B Infection Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 Medicago Inc
2.11.1 Medicago Inc Details
2.11.2 Medicago Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Medicago Inc SWOT Analysis
2.11.4 Medicago Inc Product and Services
2.11.5 Medicago Inc Influenzavirus B Infection Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.12 Novavax Inc
2.12.1 Novavax Inc Details
2.12.2 Novavax Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Novavax Inc SWOT Analysis
2.12.4 Novavax Inc Product and Services
2.12.5 Novavax Inc Influenzavirus B Infection Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.13 GlaxoSmithKline Plc
2.13.1 GlaxoSmithKline Plc Details
2.13.2 GlaxoSmithKline Plc Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 GlaxoSmithKline Plc SWOT Analysis
2.13.4 GlaxoSmithKline Plc Product and Services
2.13.5 GlaxoSmithKline Plc Influenzavirus B Infection Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.14 Romark Laboratories LC
2.14.1 Romark Laboratories LC Details
2.14.2 Romark Laboratories LC Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 Romark Laboratories LC SWOT Analysis
2.14.4 Romark Laboratories LC Product and Services
2.14.5 Romark Laboratories LC Influenzavirus B Infection Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.15 MedImmune LLC
2.15.1 MedImmune LLC Details
2.15.2 MedImmune LLC Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 MedImmune LLC SWOT Analysis
2.15.4 MedImmune LLC Product and Services
2.15.5 MedImmune LLC Influenzavirus B Infection Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.16 Kineta Inc
2.16.1 Kineta Inc Details
2.16.2 Kineta Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.16.3 Kineta Inc SWOT Analysis
2.16.4 Kineta Inc Product and Services
2.16.5 Kineta Inc Influenzavirus B Infection Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.17 Green Cross Corp
2.17.1 Green Cross Corp Details
2.17.2 Green Cross Corp Major Business and Total Revenue (Financial Highlights) Analysis
2.17.3 Green Cross Corp SWOT Analysis
2.17.4 Green Cross Corp Product and Services
2.17.5 Green Cross Corp Influenzavirus B Infection Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.18 Park Active Molecules
2.18.1 Park Active Molecules Details
2.18.2 Park Active Molecules Major Business and Total Revenue (Financial Highlights) Analysis
2.18.3 Park Active Molecules SWOT Analysis
2.18.4 Park Active Molecules Product and Services
2.18.5 Park Active Molecules Influenzavirus B Infection Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.19 Mucosis BV
2.19.1 Mucosis BV Details
2.19.2 Mucosis BV Major Business and Total Revenue (Financial Highlights) Analysis
2.19.3 Mucosis BV SWOT Analysis
2.19.4 Mucosis BV Product and Services
2.19.5 Mucosis BV Influenzavirus B Infection Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.20 Inovio Pharmaceuticals Inc
2.20.1 Inovio Pharmaceuticals Inc Details
2.20.2 Inovio Pharmaceuticals Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.20.3 Inovio Pharmaceuticals Inc SWOT Analysis
2.20.4 Inovio Pharmaceuticals Inc Product and Services
2.20.5 Inovio Pharmaceuticals Inc Influenzavirus B Infection Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.21 Vectura Group Plc
2.21.1 Vectura Group Plc Details
2.21.2 Vectura Group Plc Major Business and Total Revenue (Financial Highlights) Analysis
2.21.3 Vectura Group Plc SWOT Analysis
2.21.4 Vectura Group Plc Product and Services
2.21.5 Vectura Group Plc Influenzavirus B Infection Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.22 Sanofi
2.22.1 Sanofi Details
2.22.2 Sanofi Major Business and Total Revenue (Financial Highlights) Analysis
2.22.3 Sanofi SWOT Analysis
2.22.4 Sanofi Product and Services
2.22.5 Sanofi Influenzavirus B Infection Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.23 Vaxart Inc
2.23.1 Vaxart Inc Details
2.23.2 Vaxart Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.23.3 Vaxart Inc SWOT Analysis
2.23.4 Vaxart Inc Product and Services
2.23.5 Vaxart Inc Influenzavirus B Infection Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.24 TSRL Inc
2.24.1 TSRL Inc Details
2.24.2 TSRL Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.24.3 TSRL Inc SWOT Analysis
2.24.4 TSRL Inc Product and Services
2.24.5 TSRL Inc Influenzavirus B Infection Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.25 SK Chemicals Co Ltd
2.25.1 SK Chemicals Co Ltd Details
2.25.2 SK Chemicals Co Ltd Major Business and Total Revenue (Financial Highlights) Analysis
2.25.3 SK Chemicals Co Ltd SWOT Analysis
2.25.4 SK Chemicals Co Ltd Product and Services
2.25.5 SK Chemicals Co Ltd Influenzavirus B Infection Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.26 Sanofi Pasteur SA
2.26.1 Sanofi Pasteur SA Details
2.26.2 Sanofi Pasteur SA Major Business and Total Revenue (Financial Highlights) Analysis
2.26.3 Sanofi Pasteur SA SWOT Analysis
2.26.4 Sanofi Pasteur SA Product and Services
2.26.5 Sanofi Pasteur SA Influenzavirus B Infection Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.27 Shionogi & Co Ltd
2.27.1 Shionogi & Co Ltd Details
2.27.2 Shionogi & Co Ltd Major Business and Total Revenue (Financial Highlights) Analysis
2.27.3 Shionogi & Co Ltd SWOT Analysis
2.27.4 Shionogi & Co Ltd Product and Services
2.27.5 Shionogi & Co Ltd Influenzavirus B Infection Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Influenzavirus B Infection Drug Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Influenzavirus B Infection Drug Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Influenzavirus B Infection Drug Manufacturer Market Share in 2019
3.3.2 Top 6 Influenzavirus B Infection Drug Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Influenzavirus B Infection Drug Sales, Revenue and Market Share by Regions
4.1.1 Global Influenzavirus B Infection Drug Sales and Market Share by Regions (2015-2020)
4.1.2 Global Influenzavirus B Infection Drug Revenue and Market Share by Regions (2015-2020)
4.2 North America Influenzavirus B Infection Drug Sales and Growth Rate (2015-2020)
4.3 Europe Influenzavirus B Infection Drug Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Influenzavirus B Infection Drug Sales and Growth Rate (2015-2020)
4.5 South America Influenzavirus B Infection Drug Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Influenzavirus B Infection Drug Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Influenzavirus B Infection Drug Sales, Revenue and Market Share by Country
5.1.1 North America Influenzavirus B Infection Drug Sales and Market Share by Country (2015-2020)
5.1.2 North America Influenzavirus B Infection Drug Revenue and Market Share by Country (2015-2020)
5.2 United States Influenzavirus B Infection Drug Sales and Growth Rate (2015-2020)
5.3 Canada Influenzavirus B Infection Drug Sales and Growth Rate (2015-2020)
5.4 Mexico Influenzavirus B Infection Drug Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Influenzavirus B Infection Drug Sales, Revenue and Market Share by Country
6.1.1 Europe Influenzavirus B Infection Drug Sales and Market Share by Country (2015-2020)
6.1.2 Europe Influenzavirus B Infection Drug Revenue and Market Share by Country (2015-2020)
6.2 Germany Influenzavirus B Infection Drug Sales and Growth Rate (2015-2020)
6.3 UK Influenzavirus B Infection Drug Sales and Growth Rate (2015-2020)
6.4 France Influenzavirus B Infection Drug Sales and Growth Rate (2015-2020)
6.5 Russia Influenzavirus B Infection Drug Sales and Growth Rate (2015-2020)
6.6 Italy Influenzavirus B Infection Drug Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Influenzavirus B Infection Drug Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Influenzavirus B Infection Drug Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Influenzavirus B Infection Drug Revenue and Market Share by Regions (2015-2020)
7.2 China Influenzavirus B Infection Drug Sales and Growth Rate (2015-2020)
7.3 Japan Influenzavirus B Infection Drug Sales and Growth Rate (2015-2020)
7.4 Korea Influenzavirus B Infection Drug Sales and Growth Rate (2015-2020)
7.5 India Influenzavirus B Infection Drug Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Influenzavirus B Infection Drug Sales and Growth Rate (2015-2020)
7.7 Australia Influenzavirus B Infection Drug Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Influenzavirus B Infection Drug Sales, Revenue and Market Share by Country
8.1.1 South America Influenzavirus B Infection Drug Sales and Market Share by Country (2015-2020)
8.1.2 South America Influenzavirus B Infection Drug Revenue and Market Share by Country (2015-2020)
8.2 Brazil Influenzavirus B Infection Drug Sales and Growth Rate (2015-2020)
8.3 Argentina Influenzavirus B Infection Drug Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Influenzavirus B Infection Drug Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Influenzavirus B Infection Drug Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Influenzavirus B Infection Drug Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Influenzavirus B Infection Drug Sales and Growth Rate (2015-2020)
9.3 Turkey Influenzavirus B Infection Drug Sales and Growth Rate (2015-2020)
9.4 Egypt Influenzavirus B Infection Drug Sales and Growth Rate (2015-2020)
9.5 South Africa Influenzavirus B Infection Drug Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Influenzavirus B Infection Drug Sales and Market Share by Type (2015-2020)
10.2 Global Influenzavirus B Infection Drug Revenue and Market Share by Type (2015-2020)
10.3 Global Influenzavirus B Infection Drug Price by Type (2015-2020)
11 Global Influenzavirus B Infection Drug Market Segment by Application
11.1 Global Influenzavirus B Infection Drug Sales Market Share by Application (2015-2020)
11.2 Global Influenzavirus B Infection Drug Revenue Market Share by Application (2015-2020)
11.3 Global Influenzavirus B Infection Drug Price by Application (2015-2020)
12 Market Forecast
12.1 Global Influenzavirus B Infection Drug Sales, Revenue and Growth Rate (2021-2025)
12.2 Influenzavirus B Infection Drug Market Forecast by Regions (2021-2025)
12.2.1 North America Influenzavirus B Infection Drug Market Forecast (2021-2025)
12.2.2 Europe Influenzavirus B Infection Drug Market Forecast (2021-2025)
12.2.3 Asia-Pacific Influenzavirus B Infection Drug Market Forecast (2021-2025)
12.2.4 South America Influenzavirus B Infection Drug Market Forecast (2021-2025)
12.2.5 Middle East & Africa Influenzavirus B Infection Drug Market Forecast (2021-2025)
12.3 Influenzavirus B Infection Drug Market Forecast by Type (2021-2025)
12.3.1 Global Influenzavirus B Infection Drug Sales Forecast by Type (2021-2025)
12.3.2 Global Influenzavirus B Infection Drug Market Share Forecast by Type (2021-2025)
12.4 Influenzavirus B Infection Drug Market Forecast by Application (2021-2025)
12.4.1 Global Influenzavirus B Infection Drug Sales Forecast by Application (2021-2025)
12.4.2 Global Influenzavirus B Infection Drug Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Influenzavirus B Infection Drug Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Influenzavirus B Infection Drug by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Influenzavirus B Infection Drug Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. AbbVie Inc Basic Information, Manufacturing Base and Competitors
Table 8. AbbVie Inc Influenzavirus B Infection Drug Major Business
Table 9. AbbVie Inc Influenzavirus B Infection Drug Total Revenue (USD Million) (2018-2019)
Table 10. AbbVie Inc SWOT Analysis
Table 11. AbbVie Inc Influenzavirus B Infection Drug Product and Services
Table 12. AbbVie Inc Influenzavirus B Infection Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. ContraFect Corp Basic Information, Manufacturing Base and Competitors
Table 14. ContraFect Corp Influenzavirus B Infection Drug Major Business
Table 15. ContraFect Corp Influenzavirus B Infection Drug Total Revenue (USD Million) (2018-2019)
Table 16. ContraFect Corp SWOT Analysis
Table 17. ContraFect Corp Influenzavirus B Infection Drug Product and Services
Table 18. ContraFect Corp Influenzavirus B Infection Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Amarillo Biosciences Inc Basic Information, Manufacturing Base and Competitors
Table 20. Amarillo Biosciences Inc Influenzavirus B Infection Drug Major Business
Table 21. Amarillo Biosciences Inc Influenzavirus B Infection Drug Total Revenue (USD Million) (2018-2019)
Table 22. Amarillo Biosciences Inc SWOT Analysis
Table 23. Amarillo Biosciences Inc Influenzavirus B Infection Drug Product and Services
Table 24. Amarillo Biosciences Inc Influenzavirus B Infection Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Adimmune Corp Basic Information, Manufacturing Base and Competitors
Table 26. Adimmune Corp Influenzavirus B Infection Drug Major Business
Table 27. Adimmune Corp Influenzavirus B Infection Drug Total Revenue (USD Million) (2018-2019)
Table 28. Adimmune Corp SWOT Analysis
Table 29. Adimmune Corp Influenzavirus B Infection Drug Product and Services
Table 30. Adimmune Corp Influenzavirus B Infection Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Cadila Healthcare Ltd Basic Information, Manufacturing Base and Competitors
Table 32. Cadila Healthcare Ltd Influenzavirus B Infection Drug Major Business
Table 33. Cadila Healthcare Ltd Influenzavirus B Infection Drug Total Revenue (USD Million) (2018-2019)
Table 34. Cadila Healthcare Ltd SWOT Analysis
Table 35. Cadila Healthcare Ltd Influenzavirus B Infection Drug Product and Services
Table 36. Cadila Healthcare Ltd Influenzavirus B Infection Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Altravax Inc Basic Information, Manufacturing Base and Competitors
Table 38. Altravax Inc Influenzavirus B Infection Drug Major Business
Table 39. Altravax Inc Influenzavirus B Infection Drug Total Revenue (USD Million) (2018-2019)
Table 40. Altravax Inc SWOT Analysis
Table 41. Altravax Inc Influenzavirus B Infection Drug Product and Services
Table 42. Altravax Inc Influenzavirus B Infection Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Fujifilm Holdings Corporation Basic Information, Manufacturing Base and Competitors
Table 44. Fujifilm Holdings Corporation Influenzavirus B Infection Drug Major Business
Table 45. Fujifilm Holdings Corporation Influenzavirus B Infection Drug Total Revenue (USD Million) (2018-2019)
Table 46. Fujifilm Holdings Corporation SWOT Analysis
Table 47. Fujifilm Holdings Corporation Influenzavirus B Infection Drug Product and Services
Table 48. Fujifilm Holdings Corporation Influenzavirus B Infection Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. BioCryst Pharmaceuticals Inc Basic Information, Manufacturing Base and Competitors
Table 50. BioCryst Pharmaceuticals Inc Influenzavirus B Infection Drug Major Business
Table 51. BioCryst Pharmaceuticals Inc Influenzavirus B Infection Drug Total Revenue (USD Million) (2018-2019)
Table 52. BioCryst Pharmaceuticals Inc SWOT Analysis
Table 53. BioCryst Pharmaceuticals Inc Influenzavirus B Infection Drug Product and Services
Table 54. BioCryst Pharmaceuticals Inc Influenzavirus B Infection Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Aphios Corp Basic Information, Manufacturing Base and Competitors
Table 56. Aphios Corp Influenzavirus B Infection Drug Major Business
Table 57. Aphios Corp Influenzavirus B Infection Drug Total Revenue (USD Million) (2018-2019)
Table 58. Aphios Corp SWOT Analysis
Table 59. Aphios Corp Influenzavirus B Infection Drug Product and Services
Table 60. Aphios Corp Influenzavirus B Infection Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Daiichi Sankyo Company Ltd Basic Information, Manufacturing Base and Competitors
Table 62. Daiichi Sankyo Company Ltd Influenzavirus B Infection Drug Major Business
Table 63. Daiichi Sankyo Company Ltd Influenzavirus B Infection Drug Total Revenue (USD Million) (2018-2019)
Table 64. Daiichi Sankyo Company Ltd SWOT Analysis
Table 65. Daiichi Sankyo Company Ltd Influenzavirus B Infection Drug Product and Services
Table 66. Daiichi Sankyo Company Ltd Influenzavirus B Infection Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. Medicago Inc Basic Information, Manufacturing Base and Competitors
Table 68. Medicago Inc Influenzavirus B Infection Drug Major Business
Table 69. Medicago Inc Influenzavirus B Infection Drug Total Revenue (USD Million) (2018-2019)
Table 70. Medicago Inc SWOT Analysis
Table 71. Medicago Inc Influenzavirus B Infection Drug Product and Services
Table 72. Medicago Inc Influenzavirus B Infection Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 73. Novavax Inc Basic Information, Manufacturing Base and Competitors
Table 74. Novavax Inc Influenzavirus B Infection Drug Major Business
Table 75. Novavax Inc Influenzavirus B Infection Drug Total Revenue (USD Million) (2018-2019)
Table 76. Novavax Inc SWOT Analysis
Table 77. Novavax Inc Influenzavirus B Infection Drug Product and Services
Table 78. Novavax Inc Influenzavirus B Infection Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 79. GlaxoSmithKline Plc Basic Information, Manufacturing Base and Competitors
Table 80. GlaxoSmithKline Plc Influenzavirus B Infection Drug Major Business
Table 81. GlaxoSmithKline Plc Influenzavirus B Infection Drug Total Revenue (USD Million) (2018-2019)
Table 82. GlaxoSmithKline Plc SWOT Analysis
Table 83. GlaxoSmithKline Plc Influenzavirus B Infection Drug Product and Services
Table 84. GlaxoSmithKline Plc Influenzavirus B Infection Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 85. Romark Laboratories LC Basic Information, Manufacturing Base and Competitors
Table 86. Romark Laboratories LC Influenzavirus B Infection Drug Major Business
Table 87. Romark Laboratories LC Influenzavirus B Infection Drug Total Revenue (USD Million) (2018-2019)
Table 88. Romark Laboratories LC SWOT Analysis
Table 89. Romark Laboratories LC Influenzavirus B Infection Drug Product and Services
Table 90. Romark Laboratories LC Influenzavirus B Infection Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 91. MedImmune LLC Basic Information, Manufacturing Base and Competitors
Table 92. MedImmune LLC Influenzavirus B Infection Drug Major Business
Table 93. MedImmune LLC Influenzavirus B Infection Drug Total Revenue (USD Million) (2018-2019)
Table 94. MedImmune LLC SWOT Analysis
Table 95. MedImmune LLC Influenzavirus B Infection Drug Product and Services
Table 96. MedImmune LLC Influenzavirus B Infection Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 97. Kineta Inc Basic Information, Manufacturing Base and Competitors
Table 98. Kineta Inc Influenzavirus B Infection Drug Major Business
Table 99. Kineta Inc Influenzavirus B Infection Drug Total Revenue (USD Million) (2018-2019)
Table 100. Kineta Inc SWOT Analysis
Table 101. Kineta Inc Influenzavirus B Infection Drug Product and Services
Table 102. Kineta Inc Influenzavirus B Infection Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 103. Green Cross Corp Basic Information, Manufacturing Base and Competitors
Table 104. Green Cross Corp Influenzavirus B Infection Drug Major Business
Table 105. Green Cross Corp Influenzavirus B Infection Drug Total Revenue (USD Million) (2018-2019)
Table 106. Green Cross Corp SWOT Analysis
Table 107. Green Cross Corp Influenzavirus B Infection Drug Product and Services
Table 108. Green Cross Corp Influenzavirus B Infection Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 109. Park Active Molecules Influenzavirus B Infection Drug Type and Application
Table 110. Park Active Molecules Influenzavirus B Infection Drug Major Business
Table 111. Park Active Molecules Influenzavirus B Infection Drug Total Revenue (USD Million) (2018-2019)
Table 112. Park Active Molecules SWOT Analysis
Table 113. Park Active Molecules Influenzavirus B Infection Drug Product and Services
Table 114. Park Active Molecules Influenzavirus B Infection Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 115. Mucosis BV Basic Information, Manufacturing Base and Competitors
Table 116. Mucosis BV Influenzavirus B Infection Drug Major Business
Table 117. Mucosis BV Influenzavirus B Infection Drug Total Revenue (USD Million) (2018-2019)
Table 118. Mucosis BV SWOT Analysis
Table 119. Mucosis BV Influenzavirus B Infection Drug Product and Services
Table 120. Mucosis BV Influenzavirus B Infection Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 121. Inovio Pharmaceuticals Inc Basic Information, Manufacturing Base and Competitors
Table 122. Inovio Pharmaceuticals Inc Influenzavirus B Infection Drug Major Business
Table 123. Inovio Pharmaceuticals Inc Influenzavirus B Infection Drug Total Revenue (USD Million) (2018-2019)
Table 124. Inovio Pharmaceuticals Inc SWOT Analysis
Table 125. Inovio Pharmaceuticals Inc Influenzavirus B Infection Drug Product and Services
Table 126. Inovio Pharmaceuticals Inc Influenzavirus B Infection Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 127. Vectura Group Plc Basic Information, Manufacturing Base and Competitors
Table 128. Vectura Group Plc Influenzavirus B Infection Drug Major Business
Table 129. Vectura Group Plc Influenzavirus B Infection Drug Total Revenue (USD Million) (2018-2019)
Table 130. Vectura Group Plc SWOT Analysis
Table 131. Vectura Group Plc Influenzavirus B Infection Drug Product and Services
Table 132. Vectura Group Plc Influenzavirus B Infection Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 133. Sanofi Basic Information, Manufacturing Base and Competitors
Table 134. Sanofi Influenzavirus B Infection Drug Major Business
Table 135. Sanofi Influenzavirus B Infection Drug Total Revenue (USD Million) (2018-2019)
Table 136. Sanofi SWOT Analysis
Table 137. Sanofi Influenzavirus B Infection Drug Product and Services
Table 138. Sanofi Influenzavirus B Infection Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 139. Vaxart Inc Basic Information, Manufacturing Base and Competitors
Table 140. Vaxart Inc Influenzavirus B Infection Drug Major Business
Table 141. Vaxart Inc Influenzavirus B Infection Drug Total Revenue (USD Million) (2018-2019)
Table 142. Vaxart Inc SWOT Analysis
Table 143. Vaxart Inc Influenzavirus B Infection Drug Product and Services
Table 144. Vaxart Inc Influenzavirus B Infection Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 145. TSRL Inc Basic Information, Manufacturing Base and Competitors
Table 146. TSRL Inc Influenzavirus B Infection Drug Major Business
Table 147. TSRL Inc Influenzavirus B Infection Drug Total Revenue (USD Million) (2018-2019)
Table 148. TSRL Inc SWOT Analysis
Table 149. TSRL Inc Influenzavirus B Infection Drug Product and Services
Table 150. TSRL Inc Influenzavirus B Infection Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 151. SK Chemicals Co Ltd Basic Information, Manufacturing Base and Competitors
Table 152. SK Chemicals Co Ltd Influenzavirus B Infection Drug Major Business
Table 153. SK Chemicals Co Ltd Influenzavirus B Infection Drug Total Revenue (USD Million) (2018-2019)
Table 154. SK Chemicals Co Ltd SWOT Analysis
Table 155. SK Chemicals Co Ltd Influenzavirus B Infection Drug Product and Services
Table 156. SK Chemicals Co Ltd Influenzavirus B Infection Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 157. Sanofi Pasteur SA Basic Information, Manufacturing Base and Competitors
Table 158. Sanofi Pasteur SA Influenzavirus B Infection Drug Major Business
Table 159. Sanofi Pasteur SA Influenzavirus B Infection Drug Total Revenue (USD Million) (2018-2019)
Table 160. Sanofi Pasteur SA SWOT Analysis
Table 161. Sanofi Pasteur SA Influenzavirus B Infection Drug Product and Services
Table 162. Sanofi Pasteur SA Influenzavirus B Infection Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 163. Shionogi & Co Ltd Basic Information, Manufacturing Base and Competitors
Table 164. Shionogi & Co Ltd Influenzavirus B Infection Drug Major Business
Table 165. Shionogi & Co Ltd Influenzavirus B Infection Drug Total Revenue (USD Million) (2018-2019)
Table 166. Shionogi & Co Ltd SWOT Analysis
Table 167. Shionogi & Co Ltd Influenzavirus B Infection Drug Product and Services
Table 168. Shionogi & Co Ltd Influenzavirus B Infection Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 169. Global Influenzavirus B Infection Drug Sales by Manufacturer (2018-2019) (K Pcs)
Table 170. Global Influenzavirus B Infection Drug Revenue by Manufacturer (2018-2019) (USD Million)
Table 171. Global Influenzavirus B Infection Drug Sales by Regions (2015-2020) (K Pcs)
Table 172. Global Influenzavirus B Infection Drug Sales Market Share by Regions (2015-2020)
Table 173. Global Influenzavirus B Infection Drug Revenue by Regions (2015-2020) (USD Million)
Table 174. North America Influenzavirus B Infection Drug Sales by Countries (2015-2020) (K Pcs)
Table 175. North America Influenzavirus B Infection Drug Sales Market Share by Countries (2015-2020)
Table 176. North America Influenzavirus B Infection Drug Revenue by Countries (2015-2020) (USD Million)
Table 177. North America Influenzavirus B Infection Drug Revenue Market Share by Countries (2015-2020)
Table 178. Europe Influenzavirus B Infection Drug Sales by Countries (2015-2020) (K Pcs)
Table 179. Europe Influenzavirus B Infection Drug Sales Market Share by Countries (2015-2020)
Table 180. Europe Influenzavirus B Infection Drug Revenue by Countries (2015-2020) (USD Million)
Table 181. Asia-Pacific Influenzavirus B Infection Drug Sales by Regions (2015-2020) (K Pcs)
Table 182. Asia-Pacific Influenzavirus B Infection Drug Sales Market Share by Regions (2015-2020)
Table 183. Asia-Pacific Influenzavirus B Infection Drug Revenue by Regions (2015-2020) (USD Million)
Table 184. South America Influenzavirus B Infection Drug Sales by Countries (2015-2020) (K Pcs)
Table 185. South America Influenzavirus B Infection Drug Sales Market Share by Countries (2015-2020)
Table 186. South America Influenzavirus B Infection Drug Revenue by Countries (2015-2020) (USD Million)
Table 187. South America Influenzavirus B Infection Drug Revenue Market Share by Countries (2015-2020)
Table 188. Middle East & Africa Influenzavirus B Infection Drug Sales by Countries (2015-2020) (K Pcs)
Table 189. Middle East & Africa Influenzavirus B Infection Drug Sales Market Share by Countries (2015-2020)
Table 190. Middle East & Africa Influenzavirus B Infection Drug Revenue by Countries (2015-2020) (USD Million)
Table 191. Middle East & Africa Influenzavirus B Infection Drug Revenue Market Share by Countries (2015-2020)
Table 192. Global Influenzavirus B Infection Drug Sales by Type (2015-2020) (K Pcs)
Table 193. Global Influenzavirus B Infection Drug Sales Share by Type (2015-2020)
Table 194. Global Influenzavirus B Infection Drug Revenue by Type (2015-2020) (USD Million)
Table 195. Global Influenzavirus B Infection Drug Revenue Share by Type (2015-2020)
Table 196. Global Influenzavirus B Infection Drug Sales by Application (2015-2020) (K Pcs)
Table 197. Global Influenzavirus B Infection Drug Sales Share by Application (2015-2020)
Table 198. Global Influenzavirus B Infection Drug Sales Forecast by Regions (2021-2025) (K Pcs)
Table 199. Global Influenzavirus B Infection Drug Market Share Forecast by Regions (2021-2025)
Table 200. Global Influenzavirus B Infection Drug Sales Forecast by Type (2021-2025) (K Pcs)
Table 201. Global Influenzavirus B Infection Drug Market Share Forecast by Type (2021-2025)
Table 202. Global Influenzavirus B Infection Drug Sales Forecast by Application (2021-2025)
Table 203. Global Influenzavirus B Infection Drug Market Share Forecast by Application (2021-2025)
Table 204. Direct Channel Pros & Cons
Table 205. Indirect Channel Pros & Cons
Table 206. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Influenzavirus B Infection Drug Picture
Figure 2. Global Sales Market Share of Influenzavirus B Infection Drug by Type in 2019
Figure 3. APP-309 Picture
Figure 4. CF-403 Picture
Figure 5. GC-3106A Picture
Figure 6. KIN-1400 Picture
Figure 7. Others Picture
Figure 8. Influenzavirus B Infection Drug Sales Market Share by Application in 2018
Figure 9. Clinic Picture
Figure 10. Hospital Picture
Figure 11. Others Picture
Figure 12. Global Influenzavirus B Infection Drug Market Status and Outlook (2015-2025) (USD Million)
Figure 13. United States Influenzavirus B Infection Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Canada Influenzavirus B Infection Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Mexico Influenzavirus B Infection Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Germany Influenzavirus B Infection Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 17. France Influenzavirus B Infection Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 18. UK Influenzavirus B Infection Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Russia Influenzavirus B Infection Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Italy Influenzavirus B Infection Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 21. China Influenzavirus B Infection Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Japan Influenzavirus B Infection Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Korea Influenzavirus B Infection Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 24. India Influenzavirus B Infection Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Southeast Asia Influenzavirus B Infection Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Australia Influenzavirus B Infection Drug Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 27. Brazil Influenzavirus B Infection Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Egypt Influenzavirus B Infection Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Saudi Arabia Influenzavirus B Infection Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 30. South Africa Influenzavirus B Infection Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Turkey Influenzavirus B Infection Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 32. Global Influenzavirus B Infection Drug Sales Market Share by Manufacturer in 2019
Figure 33. Global Influenzavirus B Infection Drug Revenue Market Share by Manufacturer in 2019
Figure 34. Top 3 Influenzavirus B Infection Drug Manufacturer (Revenue) Market Share in 2019
Figure 35. Top 6 Influenzavirus B Infection Drug Manufacturer (Revenue) Market Share in 2019
Figure 36. Key Manufacturer Market Share Trend
Figure 37. Global Influenzavirus B Infection Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 38. Global Influenzavirus B Infection Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 39. Global Influenzavirus B Infection Drug Revenue Market Share by Regions (2015-2020)
Figure 40. Global Influenzavirus B Infection Drug Revenue Market Share by Regions in 2018
Figure 41. North America Influenzavirus B Infection Drug Sales and Growth Rate (2015-2020)
Figure 42. Europe Influenzavirus B Infection Drug Sales and Growth Rate (2015-2020)
Figure 43. Asia-Pacific Influenzavirus B Infection Drug Sales and Growth Rate (2015-2020)
Figure 44. South America Influenzavirus B Infection Drug Sales and Growth Rate (2015-2020)
Figure 45. Middle East & Africa Influenzavirus B Infection Drug Sales and Growth Rate (2015-2020)
Figure 46. North America Influenzavirus B Infection Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 47. North America Influenzavirus B Infection Drug Sales Market Share by Countries (2015-2020)
Figure 48. North America Influenzavirus B Infection Drug Sales Market Share by Countries in 2018
Figure 49. North America Influenzavirus B Infection Drug Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 50. North America Influenzavirus B Infection Drug Revenue Market Share by Countries in 2018
Figure 51. United States Influenzavirus B Infection Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 52. Canada Influenzavirus B Infection Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 53. Mexico Influenzavirus B Infection Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 54. Europe Influenzavirus B Infection Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 55. Europe Influenzavirus B Infection Drug Revenue Market Share by Countries (2015-2020)
Figure 56. Europe Influenzavirus B Infection Drug Revenue Market Share by Countries in 2019
Figure 57. Germany Influenzavirus B Infection Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 58. UK Influenzavirus B Infection Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 59. France Influenzavirus B Infection Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 60. Russia Influenzavirus B Infection Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 61. Italy Influenzavirus B Infection Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 62. Asia-Pacific Influenzavirus B Infection Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 63. Asia-Pacific Influenzavirus B Infection Drug Sales Market Share by Regions 2019
Figure 64. Asia-Pacific Influenzavirus B Infection Drug Revenue Market Share by Regions 2019
Figure 65. China Influenzavirus B Infection Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 66. Japan Influenzavirus B Infection Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 67. Korea Influenzavirus B Infection Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 68. India Influenzavirus B Infection Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 69. Southeast Asia Influenzavirus B Infection Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 70. South America Influenzavirus B Infection Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 71. South America Influenzavirus B Infection Drug Sales Market Share by Countries in 2019
Figure 72. South America Influenzavirus B Infection Drug Revenue Market Share by Countries in 2019
Figure 73. Brazil Influenzavirus B Infection Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 74. Argentina Influenzavirus B Infection Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 75. Middle East and Africa Influenzavirus B Infection Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 76. Middle East and Africa Influenzavirus B Infection Drug Sales Market Share by Countries in 2019
Figure 77. Middle East and Africa Influenzavirus B Infection Drug Revenue Market Share by Countries (2015-2020)
Figure 78. Middle East and Africa Influenzavirus B Infection Drug Revenue Market Share by Countries in 2019
Figure 79. Saudi Arabia Influenzavirus B Infection Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 80. Egypt Influenzavirus B Infection Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 81. Turkey Influenzavirus B Infection Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 82. South Africa Influenzavirus B Infection Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 83. Global Influenzavirus B Infection Drug Sales and Growth Rate (2021-2025) (K Pcs)
Figure 84. Global Influenzavirus B Infection Drug Revenue and Growth Rate (2021-2025) (USD Million)
Figure 85. North America Sales Influenzavirus B Infection Drug Market Forecast (2021-2025) (K Pcs)
Figure 86. Europe Sales Influenzavirus B Infection Drug Market Forecast (2021-2025) (K Pcs)
Figure 87. Asia-Pacific Sales Influenzavirus B Infection Drug Market Forecast (2021-2025) (K Pcs)
Figure 88. South America Sales Influenzavirus B Infection Drug Market Forecast (2021-2025) (K Pcs)
Figure 89. Middle East & Africa Sales Influenzavirus B Infection Drug Market Forecast (2021-2025) (K Pcs)
Figure 90. Sales Channel: Direct Channel vs Indirect Channel
クレブシエラ肺炎感染症治療薬の世界市場 2020年 Market Overview The global Klebsiella Pneumoniae Infection Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Klebsiel…- 院内感染診断の世界市場 2020年 Market Overview The global Hospital-acquired Infection Diagnostics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Hospi…
- 院内感染制御感染症の世界市場 2020年 Market Overview The global Healthcare-Acquired Infection market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Healthcare-Acqu…
- ペプチドベース感染症治療薬の世界市場 2020年 Market Overview The global Peptide Based Infection Therapeutics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 5.1% in the forecast period of 2020 to 2025 and will expected to reach USD 28730 million by 2025, from USD 23550 million in 2019. The P…
- マールブルクウイルス感染症の世界市場 2020年 Market Overview The global Marburgvirus Infection market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Marburgvirus Infection…